Study for Multiple Doses of HM15136(Efpegerglucagon) in Obese or Overweight Subjects With Comorbidities
Clinical trial NCT04167553 · COMPLETED
Trial details
- NCT number
- NCT04167553
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-30
- Primary completion
- 2020-12-09
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.